We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 42.6%
This Fund
S&P 500
This Quarter Est. Return
+10.44%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$245M
AUM Growth
+$21.3M
Cap. Flow
+$3.16M
Cap. Flow %
1.29%
Top 10 Hldgs %
67.31%
Holding
121
New
11
Increased
28
Reduced
53
Closed
9

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$2.24M
2
CVS icon
CVS Health
CVS
+$2.2M
3
NOK icon
Nokia
NOK
+$2M
4
ROKU icon
Roku
ROKU
+$1.16M
5
TPIC
TPI Composites
TPIC
+$980K

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$2.65M
2
CRCM
CARE.COM, INC.
CRCM
+$2.02M
3
ORBC
ORBCOMM, Inc.
ORBC
+$765K
4
ENPH icon
Enphase Energy
ENPH
+$516K
5
ENZ
Enzo Biochem, Inc.
ENZ
+$404K

Sector Composition

Rank Sector Weight
1 Financials 56.13%
2 Technology 17.14%
3 Healthcare 6.89%
4 Energy 5.17%
5 Industrials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMMR icon
101
Immersion
IMMR
$247M
$167K 0.07%
22,000
-3,000
-12% -$25.3K
B
102
Barrick Mining
B
$61.6B
$157K 0.06%
10,000
– –
RJET
103
Republic Airways Holdings
RJET
$997M
$137K 0.06%
1,000
– –
OPCH icon
104
Option Care Health
OPCH
$3.41B
$122K 0.05%
11,811
+1,062
+10% +$8.69K
CPE
105
DELISTED
Callon Petroleum Company
CPE
$107K 0.04%
1,625
-1,988
-55% -$143K
XONE
106
DELISTED
The ExOne Company
XONE
$93K 0.04%
10,000
– –
IDN icon
107
Intellicheck
IDN
$73.3M
$91K 0.04%
15,875
-925
-6% -$3.96K
CFMS
108
DELISTED
Conformis, Inc. Common Stock
CFMS
$78K 0.03%
720
-160
-18% -$13.2K
BCRH
109
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$77K 0.03%
11,750
+865
+8% +$6.09K
APEX
110
DELISTED
Apex Global Brands Inc. Common Stock
APEX
$32K 0.01%
2,667
-333
-11% -$7.36K
HL icon
111
Hecla Mining
HL
$9.51B
$22K 0.01%
12,500
– –
WYY icon
112
WidePoint Corp
WYY
$103M
$20K 0.01%
5,000
– –
ABBV icon
113
AbbVie
ABBV
$446B
– –
-2,516
Closed -$202K
AMBA icon
114
Ambarella
AMBA
$3.29B
– –
-7,000
Closed -$302K
DD icon
115
DuPont de Nemours
DD
$18.5B
– –
-19,656
Closed -$2.65M
HLIT icon
116
Harmonic Inc
HLIT
$1.25B
– –
-22,375
Closed -$121K
MU icon
117
Micron Technology
MU
$940B
– –
-5,000
Closed -$206K
ABMD
118
DELISTED
Abiomed Inc
ABMD
– –
-780
Closed -$222K
FLXN
119
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-11,750
Closed -$146K
CRCM
120
DELISTED
CARE.COM, INC.
CRCM
– –
-102,175
Closed -$2.02M
FTR
121
DELISTED
Frontier Communications Corp.
FTR
– –
-30,988
Closed -$61K
1 2 3 4
5

Similar funds

LI
Lafayette Investments Ashton, Maryland $494M AUM 11.42% 1-Year Est. Return
SAS
Stelac Advisory Services New York $494M AUM 23.25% 1-Year Est. Return
BFIC
Bedell Frazier Investment Counselling Walnut Creek, California $495M AUM 29.32% 1-Year Est. Return
FSA
Financial Sense Advisors San Diego, California $493M AUM 50.68% 1-Year Est. Return
TAM
Talaria Asset Management Melbourne, Australia $495M AUM 21.62% 1-Year Est. Return
CH
Canton Hathaway Providence, Rhode Island $496M AUM 14.21% 1-Year Est. Return
TAA
Turiya Advisors Asia Hong Kong $496M AUM 75.42% 1-Year Est. Return
CWM
Cranbrook Wealth Management Bloomfield Hills, Michigan $492M AUM 14.37% 1-Year Est. Return

Marathon Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Marathon Capital Management held 121 positions worth $245M, up 9.5% from $224M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Marathon Capital Management's Q2 2019 filing shows 11 new, 28 increased, 53 reduced and 9 closed positions. Its largest new stake was Myriad Genetics: 79,460 shares worth $2.21M. The largest sale was DuPont de Nemours, an estimated $2.65M.

By sector, the portfolio is most concentrated in Financials at 56% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.

  • Marathon Capital Management's largest Q2 2019 buy was Myriad Genetics: 79,460 shares worth $2.21M.
  • Marathon Capital Management added most to Nokia in Q2 2019, an estimated $2M increase.
  • Marathon Capital Management's biggest Q2 2019 reduction was ORBCOMM, Inc., cutting an estimated $765K.
  • Marathon Capital Management fully exited DuPont de Nemours in Q2 2019, selling an estimated $2.65M.
  • Marathon Capital Management's ten largest holdings make up 67% of its $245M portfolio in Q2 2019.
  • Marathon Capital Management opened 11 new positions and closed 9 in Q2 2019.
  • Marathon Capital Management's portfolio value rose 9.5% quarter-over-quarter to $245M.

Based on Marathon Capital Management's 13F filing for Q2 2019, filed 25 Jul 2019.